Half-year report · HY
8095.TEDINET S100YQAP
Period2025-12-01 → 2026-05-31
Filed2026-07-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥34.6bn | 2025-12-01 → 2026-05-31 | Cons. | Net sales |
| Revenue | ¥62.7bn | 2024-12-01 → 2025-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥30.1bn | 2024-12-01 → 2025-05-31 | Cons. | Net sales |
| Operating income | ¥2.3bn | 2025-12-01 → 2026-05-31 | Cons. | Operating income |
| Operating income | ¥2.2bn | 2024-12-01 → 2025-05-31 | Cons. | Operating income |
| Ordinary income | ¥2.1bn | 2025-12-01 → 2026-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.9bn | 2024-12-01 → 2025-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.1bn | 2024-12-01 → 2025-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.1bn | 2025-12-01 → 2026-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.0bn | 2024-12-01 → 2025-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.4bn | 2025-12-01 → 2026-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.2bn | 2024-12-01 → 2025-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.3bn | 2024-12-01 → 2025-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.4bn | 2025-12-01 → 2026-05-31 | Cons. | Profit loss |
| Net income | ¥1.3bn | 2024-12-01 → 2025-05-31 | Cons. | Profit loss |
| Total assets | ¥74.9bn | at 2026-05-31 | Cons. | Assets |
| Total assets | ¥75.9bn | at 2025-11-30 | Cons. | Assets |
| Total assets | ¥65.5bn | at 2025-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥46.1bn | at 2026-05-31 | Cons. | Liabilities |
| Total liabilities | ¥48.5bn | at 2025-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥28.8bn | at 2026-05-31 | Cons. | Net assets |
| Net assets / equity | ¥27.4bn | at 2025-11-30 | Cons. | Net assets |
| Net assets / equity | ¥26.0bn | at 2025-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.6bn | at 2026-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.2bn | at 2025-11-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.6bn | at 2026-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.1bn | at 2025-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.2bn | at 2025-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.0bn | at 2024-11-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.6bn | 2025-12-01 → 2026-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.4bn | 2024-12-01 → 2025-11-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.5bn | 2025-12-01 → 2026-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.6bn | 2024-12-01 → 2025-11-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.6bn | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.6bn | 2025-12-01 → 2026-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥6.2bn | 2024-12-01 → 2025-11-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥775m | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥35.1 | 2025-12-01 → 2026-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥54.36 | 2024-12-01 → 2025-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.97 | 2024-12-01 → 2025-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 38.0% | at 2026-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.7% | at 2025-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.5% | at 2025-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-12-01 → 2026-05-31 | ¥38m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-12-01 → 2026-05-31 | ¥35m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-12-01 → 2026-05-31 | −¥128m |
| Reconciling Itemsreconciling | revenue | 2025-12-01 → 2026-05-31 | −¥648m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-12-01 → 2026-05-31 | −¥648m |
| Reconciling Itemsreconciling | segment profit | 2025-12-01 → 2026-05-31 | ¥68m |
| Fine Chemicalsreportable segment | revenue | 2025-12-01 → 2026-05-31 | ¥11.4bn |
| Fine Chemicalsreportable segment | revenue external | 2025-12-01 → 2026-05-31 | ¥10.9bn |
| Fine Chemicalsreportable segment | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥434m |
| Fine Chemicalsreportable segment | segment profit | 2025-12-01 → 2026-05-31 | ¥729m |
| Health And Beauty Care Foodreportable segment | revenue | 2025-12-01 → 2026-05-31 | ¥11.4bn |
| Health And Beauty Care Foodreportable segment | revenue external | 2025-12-01 → 2026-05-31 | ¥11.4bn |
| Health And Beauty Care Foodreportable segment | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥37m |
| Health And Beauty Care Foodreportable segment | segment profit | 2025-12-01 → 2026-05-31 | ¥360m |
| Industrial Chemicalsreportable segment | revenue | 2025-12-01 → 2026-05-31 | ¥6.0bn |
| Industrial Chemicalsreportable segment | revenue external | 2025-12-01 → 2026-05-31 | ¥6.0bn |
| Industrial Chemicalsreportable segment | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥1m |
| Industrial Chemicalsreportable segment | segment profit | 2025-12-01 → 2026-05-31 | ¥606m |
| Medicalreportable segment | revenue | 2025-12-01 → 2026-05-31 | ¥6.4bn |
| Medicalreportable segment | revenue external | 2025-12-01 → 2026-05-31 | ¥6.3bn |
| Medicalreportable segment | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥172m |
| Medicalreportable segment | segment profit | 2025-12-01 → 2026-05-31 | ¥658m |
| —segment total | revenue | 2025-12-01 → 2026-05-31 | ¥35.2bn |
| —segment total | revenue external | 2025-12-01 → 2026-05-31 | ¥34.5bn |
| —segment total | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥645m |
| —segment total | segment profit | 2025-12-01 → 2026-05-31 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-12-01 → 2026-05-31 | ¥35.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-12-01 → 2026-05-31 | ¥34.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥648m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-12-01 → 2026-05-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-12-01 → 2025-05-31 | ¥25m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-12-01 → 2025-05-31 | ¥17m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥7m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-12-01 → 2025-05-31 | −¥202m |
| Reconciling Itemsreconciling | revenue | 2024-12-01 → 2025-05-31 | −¥529m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-12-01 → 2025-05-31 | −¥529m |
| Reconciling Itemsreconciling | segment profit | 2024-12-01 → 2025-05-31 | ¥139m |
| Fine Chemicalsreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥11.9bn |
| Fine Chemicalsreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥11.6bn |
| Fine Chemicalsreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥319m |
| Fine Chemicalsreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥871m |
| Health And Beauty Care Foodreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥8.1bn |
| Health And Beauty Care Foodreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥8.0bn |
| Health And Beauty Care Foodreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥48m |
| Health And Beauty Care Foodreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥544m |
| Industrial Chemicalsreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥4.5bn |
| Industrial Chemicalsreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥4.5bn |
| Industrial Chemicalsreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥1m |
| Industrial Chemicalsreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥190m |
| Medicalreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥6.2bn |
| Medicalreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥6.0bn |
| Medicalreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥152m |
| Medicalreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥679m |
| —segment total | revenue | 2024-12-01 → 2025-05-31 | ¥30.6bn |
| —segment total | revenue external | 2024-12-01 → 2025-05-31 | ¥30.1bn |
| —segment total | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥521m |
| —segment total | segment profit | 2024-12-01 → 2025-05-31 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-12-01 → 2025-05-31 | ¥30.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-12-01 → 2025-05-31 | ¥30.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥529m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-12-01 → 2025-05-31 | ¥2.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 597
| Item | Context | Value | Unit |
|---|---|---|---|
| Foreign exchange losses noe | InterimDuration | 31000000 | JPY |
| Other noe | Prior1InterimDuration | 50000000 | JPY |
| Other noe | InterimDuration | 58000000 | JPY |
| Non operating expenses | Prior1InterimDuration | 268000000 | JPY |
| Non operating expenses | InterimDuration | 306000000 | JPY |
| Ordinary income | Prior1InterimDuration | 2149000000 | JPY |
| Ordinary income | InterimDuration | 2148000000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1InterimDuration | 2000000 | JPY |
| Gain on sales of noncurrent assets ei | InterimDuration | 0 | JPY |
| Gain on sales of investment securities ei | Prior1InterimDuration | 8000000 | JPY |
| Gain on sales of investment securities ei | InterimDuration | 0 | JPY |
| Extraordinary income | Prior1InterimDuration | 10000000 | JPY |
| Extraordinary income | InterimDuration | 0 | JPY |
| Loss on sales of noncurrent assets el | Prior1InterimDuration | 0 | JPY |
| Loss on sales of noncurrent assets el | InterimDuration | － | JPY |
| Loss on disposal of noncurrent assets el | Prior1InterimDuration | 9000000 | JPY |
| Loss on disposal of noncurrent assets el | InterimDuration | 6000000 | JPY |
| Impairment loss el | Prior1InterimDuration | 118000000 | JPY |
| Impairment loss el | InterimDuration | － | JPY |
| Extraordinary loss | Prior1InterimDuration | 128000000 | JPY |
| Extraordinary loss | InterimDuration | 6000000 | JPY |
| Income before income taxes | Prior1InterimDuration | 2032000000 | JPY |
| Income before income taxes | InterimDuration | 2143000000 | JPY |
| Income taxes current | Prior1InterimDuration | 549000000 | JPY |
| Income taxes current | InterimDuration | 544000000 | JPY |
| Income taxes deferred | Prior1InterimDuration | 201000000 | JPY |
| Income taxes deferred | InterimDuration | 182000000 | JPY |
| Income taxes | Prior1InterimDuration | 750000000 | JPY |
| Income taxes | InterimDuration | 726000000 | JPY |
| Profit loss | Prior1InterimDuration | 1281000000 | JPY |
| Profit loss | InterimDuration | 1417000000 | JPY |
| Profit loss attributable to non controlling interests | Prior1InterimDuration | -7000000 | JPY |
| Profit loss attributable to non controlling interests | InterimDuration | -0 | JPY |
| Profit loss attributable to owners of parent | Prior1InterimDuration | 1288000000 | JPY |
| Profit loss attributable to owners of parent | InterimDuration | 1417000000 | JPY |
| Profit loss | Prior1InterimDuration | 1281000000 | JPY |
| Profit loss | InterimDuration | 1417000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1InterimDuration | -158000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | InterimDuration | 189000000 | JPY |
| Deferred gains or losses on hedges net of tax oci | Prior1InterimDuration | 2000000 | JPY |
| Deferred gains or losses on hedges net of tax oci | InterimDuration | 1000000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1InterimDuration | -45000000 | JPY |
| Foreign currency translation adjustment net of tax oci | InterimDuration | 110000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1InterimDuration | -42000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | InterimDuration | -46000000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | Prior1InterimDuration | -0 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | InterimDuration | － | JPY |
| Other comprehensive income | Prior1InterimDuration | -244000000 | JPY |
| Other comprehensive income | InterimDuration | 256000000 | JPY |
| Comprehensive income | Prior1InterimDuration | 1036000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |